DeSci Suddenly Becomes a Hot Topic Again, Binance Labs Invests in BIO Protocol, and Meme Tokens RIF and URO Increase by 20 Times in Two Days

In the past week, DeSci has suddenly become a hot topic of discussion again. Since Binance Labs announced its investment in BIO Protocol, tokens in the DeSci field such as VITA, GROW, and RSC have all seen significant increases, maintaining strong performance even during the recent market correction.

Recently, DeSci has once again become a hot topic of discussion. Following Binance Labs' announcement of its investment in the BIO Protocol, tokens in the DeSci field, such as VITA, GROW, and RSC, have seen significant increases, maintaining strong performance even during the recent market correction. The previously low-profile BIO Genesis event was quickly filled to capacity, and even the pump experimental platform launched by the BIO team has been "revived." It seems that all the crypto hot money is now flowing into DeSci.

The "revived" official experiment

The meme market continues to thrive. From various narrative angles, meme coins in the DeSci field, RIF and URO, have increased by 20 times in less than two days. These two tokens come from the Pump.science platform and represent the compounds Rifampicin (RIF) and Urokinase (URO).

Pump.science is a meme token platform launched by the DeSci project Molecule DAO, which carries out medical experiments through meme coins. The tokens RIF and URO did not generate much buzz upon their launch, with a market cap hovering around $150,000. However, in the past two days, RIF and URO have continuously broken new highs, with a market cap reaching nearly $3 million, marking a 20-fold increase.

Pump.Science is a meme token platform introduced by Molecule DAO at this year's Token 2049 Solana Breakpoint conference, where players can purchase meme tokens representing drugs and participate in predicting drug effects and trading experimental data. The recent "resurrection" of Pump.science can be attributed to Binance's frequent actions in the DeSci field.

On November 8, Binance Labs announced its investment in the BIO Protocol, stating that this investment marks Binance Labs' first foray into the decentralized science (DeSci) field. Less than a week after this announcement, CZ attended the DeSci Day event held by Binance in Bangkok and discussed DeSci insights with Vitalik.

Regarding the BIO Protocol, it focuses on the medical research field, using blockchain technology to change the financing and commercialization methods of early scientific research. Paul Kohlhaas, the founder of the BIO Protocol, has stated that the BIO Protocol aims to break the traditional funding bottleneck in scientific research, promoting patient-driven research globally and bringing about revolutionary changes.

At the DeSci Day event in Bangkok, Vitalik Buterin also showcased VitaDAO's first longevity product—VD001, a natural high-dose spermidine supplement approved by the Thai FDA. CZ expressed his hope to see "1,000 DeSci projects" by next year.

In these few days, various DeSci project tokens have seen significant price increases. In addition to the RIF and URO mentioned at the beginning of the article, the VitaDAO token VITA and the DeSci project ResearchCoin token RSC have also shown impressive gains.

The favorite track of crypto tycoons?

In fact, DeSci has always had a high "reputation."

As early as last year, the DeSci concept sparked a wave of enthusiasm in the Chinese community, attracting CZ's attention with its innovations in longevity research. He mentioned that he has been paying attention to biotechnology and thinking about how to use crypto technology to accelerate the flow of research funding in this field, which became a key point for the resurgence of DeSci.

Not only CZ, but several industry leaders also participated in the DeSci conference held in Berlin at the end of last year, such as Matti, the co-founder of Zee Prime Capital, and Tyler Golato, the CEO of Molecule. They actively shared their research and insights on DeSci and had high expectations for the field.

More than a month ago, a16z also made its first foray into the DeSci field by leading an investment in AminoChain, a DeSci project aimed at reforming the patient contribution of biological samples in the medical field. Binance has also repeatedly hinted on social media that it is ready to leverage blockchain technology to strongly support scientific projects. CZ stated, "Innovation often occurs in small groups, and we need decentralized science because many excellent researchers cannot obtain sufficient funding."

It is foreseeable that, with Binance's promotion, the DeSci field will attract more and more attention.

Which projects to watch?

The BIO Protocol, which received investment from Binance Labs, aims to build a global research funding and collaboration platform using blockchain and DAO, hoping to leverage blockchain technology to address currently challenging issues such as rare diseases, longevity research, and emerging health. The BIO Protocol network currently has seven BIO DAOs covering various directions, including cryopreservation, women's health, and mental health. The protocol token BIO and the tokens of its partner DAOs can be considered as points of interest.

On August 9, the BIO Protocol launched its first round of Bio Genesis token sales, with an average price of $0.025 and a trading volume of $1